Xponance’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Buy |
410,983
+47,004
| +13% | +$2.18M | 0.16% | 102 |
|
|
2025
Q1 | $22.2M | Buy |
363,979
+30,040
| +9% | +$1.83M | 0.21% | 76 |
|
|
2024
Q4 | $18.9M | Buy |
333,939
+11,370
| +4% | +$643K | 0.17% | 93 |
|
|
2024
Q3 | $16.7M | Buy |
322,569
+5,188
| +2% | +$268K | 0.16% | 99 |
|
|
2024
Q2 | $13.2M | Buy |
317,381
+25,543
| +9% | +$1.06M | 0.13% | 121 |
|
|
2024
Q1 | $15.8M | Buy |
291,838
+14,369
| +5% | +$779K | 0.17% | 110 |
|
|
2023
Q4 | $14.2M | Buy |
277,469
+20,030
| +8% | +$1.03M | 0.17% | 103 |
|
|
2023
Q3 | $14.9M | Buy |
257,439
+3,231
| +1% | +$188K | 0.2% | 84 |
|
|
2023
Q2 | $16.3M | Sell |
254,208
-4,816
| -2% | -$308K | 0.22% | 79 |
|
|
2023
Q1 | $18M | Buy |
259,024
+5,329
| +2% | +$369K | 0.26% | 71 |
|
|
2022
Q4 | $18.3M | Buy |
253,695
+34,161
| +16% | +$2.46M | 0.3% | 68 |
|
|
2022
Q3 | $15.6M | Buy |
219,534
+47,993
| +28% | +$3.41M | 0.3% | 59 |
|
|
2022
Q2 | $13.2M | Buy |
171,541
+25,261
| +17% | +$1.95M | 0.27% | 69 |
|
|
2022
Q1 | $10.7M | Buy |
146,280
+1,898
| +1% | +$139K | 0.18% | 92 |
|
|
2021
Q4 | $9M | Sell |
144,382
-26,888
| -16% | -$1.68M | 0.14% | 127 |
|
|
2021
Q3 | $10.1M | Sell |
171,270
-11,563
| -6% | -$684K | 0.19% | 92 |
|
|
2021
Q2 | $12.2M | Sell |
182,833
-78,458
| -30% | -$5.24M | 0.22% | 79 |
|
|
2021
Q1 | $16.5M | Sell |
261,291
-2,186
| -0.8% | -$138K | 0.35% | 55 |
|
|
2020
Q4 | $16.3M | Buy |
263,477
+3,201
| +1% | +$199K | 0.36% | 52 |
|
|
2020
Q3 | $15.7M | Sell |
260,276
-17,773
| -6% | -$1.07M | 0.39% | 51 |
|
|
2020
Q2 | $16.3M | Buy |
+278,049
| New | +$16.3M | 0.42% | 48 |
|